Ozone Litigation: What You Need to Know (December Update)

Ozempic is the brand name for the drug semaglutide, one of the newest weight management drugs on the market. It has recently been in the news as an effective anti-obesity drug.

However, Ozempic has also received widespread attention for potentially dangerous side effects, such as gallbladder disease and gastroparesis (reduced stomach function that can lead to stomach pain and vomiting). As users of the drug become aware of these side effects, some have begun taking legal action. This article will detail the background and timeline of the Ozempic litigation and provide an update on the case’s progress through the legal system.

Ozone litigation update

Legal action against Ozempic (and against semaglutide’s other brands, Wegovy and Rybelsus), is in its infancy. As of this update, there are no multidistrict or class action lawsuits filed. There are only a handful of individual lawsuits against Novo Nordisk, the maker of Ozempic.

However, this may soon change. Lawyers for the province of British Columbia have filed a class-action lawsuit against Novo Nordisk in the Supreme Court of British Columbia. The lawsuit has not yet been approved by a judge. However, if it does get authorization, it could become the world’s first class action lawsuit against Ozempic.

The action comes a month after the FDA added additional side effects to Ozempic’s warning label.

The history of ozone

Initially, Ozempic was not an anti-obesity drug. Instead, when semaglutide was developed, it was intended as a diabetes treatment. When Ozempic became available to the public in 2017, it was approved by the FDA as a drug to control the effects of diabetes.

However, less than a year after Ozempic was released in 2017, researchers at the University of Leeds discovered that the drug could also be used to treat obesity. Just a few years later, in 2021, the FDA approved Wegovy for long-term weight management in adults with at least one other weight-related condition.

The drug quickly became a popular choice for weight management in the United States and around the world. However, in less than a year, the FDA Adverse Event Notification System (FAERS) has received more than 10,000 adverse event reports regarding semaglutide variants.

Despite numerous reports of adverse events, semaglutide remained a popular weight management option for the next two years. It’s so popular that the FDA added it to the Shortage Drug List in 2023.

Around this time, mainstream news outlets began reporting on Ozempic’s alleged side effects. The first lawsuit was filed shortly after the information became public.

Get your free Ozone case review

Have you experienced severe gastroparesis or other side effects after taking Ozempic? You may be eligible for substantial compensation.

start using

Allegations in Ozone Lawsuit

Plaintiffs in the Ozempic lawsuit claim the drug causes a dangerous condition called gastroparesis. Case reports linking this drug to gastroparesis can be found in the National Library of Medicine database.

Gastroparesis is a chronic disease in which the nerves and muscles of the stomach lining are severely weakened. This weakening makes it harder for the stomach to move food to the small intestine. The results of gastroparesis include a blockage or blockage in the intestines, often leading to nausea and diarrhea.

In addition, gastroparesis cannot be cured and can only be treated with medication and surgery. This means anyone with the disease is likely to face lifelong medical intervention.

Other alleged ozone side effects

There have been lawsuits filed over Ozempic’s side effects related to the stomach and stomach wall muscles. The plaintiffs claim Novo Nordisk concealed or downplayed these side effects, but there are other potential side effects that could lead to further legal action.

Possible link to suicidal ideation

The European Medicines Agency is also currently reviewing data showing a possible link between semaglutide and suicidal ideation. The agency has received at least 150 reports of people having suicidal thoughts while taking Ozempic.

In the United States, Wegovy must issue a warning about suicidal behavior. However, in the United States, this warning is required for all chronic weight loss medications. Semaglutide may reflect a higher risk than other weight management medications. But so far, no lawsuit filed by Ozempic is based on this allegation.

Link to gallbladder disease

In a study published in the Journal of the American Medical Association, researchers found that use of drugs such as Ozempic, Rybelsus and Wegovy was associated with an increased risk of gallbladder disease. These drugs all act as glucagon-like peptide-1 receptor agonists (GLP-1 RA) hormones. A 2022 review of 76 studies on the effects of these GLP-1 RAs confirmed a link to gallbladder disease.

So far, no lawsuits have been filed against Novo Nordisk or the makers of Rybelsus or Wegovy, but patients who used these drugs and were diagnosed with gallbladder disease may file lawsuits in the future.

Novo Nordisk defends ozone lawsuit

Novo Nordisk has issued public statements attesting to the safety of its products, including all semaglutide variants. As part of these statements, the company acknowledged that gastrointestinal side effects may occur with the use of its drugs but downplayed their severity.

According to Novo Nordisk, these side effects were mild to moderate and short-lived. Additionally, the manufacturer emphasizes that these effects are listed on the drug’s warning label.

This may be Novo Nordisk’s main defense against the Ozempic lawsuit. The company may claim that users are warned of potential side effects before starting to take the drug.

Standing to File an Ozone Lawsuit

To date, every Ozempic lawsuit has been filed by people who used the drug and developed gastrointestinal problems. Lawyers will generally only accept clients who can prove that they have experienced chronic vomiting or diarrhea for a month or more. This is a relatively small proportion of people who use the drug.

If the only harm you have suffered from taking Ozempic is suicidal ideation, you may try talking to an attorney. However, unless there is more data linking semaglutide to suicidal thoughts, few lawyers will accept you as a plaintiff. Such proceedings may become feasible after the European Medicines Agency completes its analysis of data on such links.

Available Damages in Ozone Lawsuits

Damages awarded in any lawsuit depend on the injuries and losses suffered by the plaintiff. However, Jaclyn Bjorklund, for example, is seeking compensatory and punitive damages.

These compensatory damages include medical expenses incurred for severe gastrointestinal problems. Bjorklund suffered severe permanent injuries, including tooth loss and internal damage. In addition, Bjorklund was hospitalized several times. She is seeking compensation for past medical bills and any ongoing expenses.

Bjorklund is also seeking punitive damages for the pain and suffering caused by Novo Nordisk’s conduct. Finally, she is seeking compensation for court costs and attorney fees. A similar lawsuit may seek the same type of damages and approximately the same amount as the plaintiff is seeking.

The future of ozone litigation

The first Ozempic lawsuits are just starting to make their way through the legal process. At this time, no meaningful discoveries have been made and no lawsuits have been resolved.

Based on current efforts to initiate class action lawsuits in Canada, it is possible that additional class action or multi-district litigation will be filed in the coming months and years. This usually occurs when enough plaintiffs file similar lawsuits in a sufficiently short period of time.

The long-term progress of these lawsuits may depend on the outcome of the earliest lawsuits. and there is insufficient information to determine whether plaintiffs are likely to win or lose these cases.

However, the longer it takes to complete the case, the more data will become available on the potential association between semaglutide and gastroparesis. Several researchers have recently investigated this link, releasing several reports in the past few months.

Currently, at least one lawsuit (filed by Jaclyn Bjorklund) claims that Novo Nordisk was aware of the link between its product and gastroparesis before releasing the drug. If Bjorklund’s attorneys can prove this claim in court, attorneys in future Ozempic lawsuits may follow suit and make similar claims.

Ozone Litigation – Free Case Review

Have you experienced severe gastroparesis or other side effects after taking Ozempic? You may be eligible for substantial compensation. Find out if you qualify.

Fake Ozempic

There is another factor that could affect the outcome of the Ozempic lawsuit. In June 2023, Novo Nordisk issued a statement saying that a fake Ozempic pen was found in the United States.

The product in the pen is another diabetes medication. People who have used this product have experienced adverse reactions after injecting it.

The presence of counterfeit products can complicate any litigation. Plaintiffs must prove they were using Ozempic and not a counterfeit weight management drug. Additionally, if counterfeit products become more common, reporting of adverse events may become unreliable.

Have you experienced severe gastroparesis or other side effects after taking Ozempic?

You may be eligible for substantial compensation. Get your free case review now.

#Ozone #Litigation #December #Update
Image Source : www.forbes.com

Leave a Comment